REINHARDT MAX

CIK 00017800582 companiesLEWISVILLE, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001780058

Recent Transactions

41 trades

Sale
Orthofix Medical Inc.$OFIX
Common Stock
2025-06-11$11.64/sh−1,643→ 27,481 total
Award
Orthofix Medical Inc.$OFIX
Employee Stock Option (Right to Buy)
2025-03-03+34,924→ 34,924 total
Award
Orthofix Medical Inc.$OFIX
Common Stock
2025-03-03+14,723→ 29,124 total
Award
Orthofix Medical Inc.$OFIX
Employee Stock Option (Right to Buy)
2024-06-10+190,731→ 190,731 total
Award
Orthofix Medical Inc.$OFIX
Common Stock
2024-06-10$13.02/sh+14,401→ 14,401 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-07$37.87/sh−1,099→ 29,225 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-06$38.99/sh−1,054→ 30,324 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-10-07$58.00/sh−1,380→ 31,378 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-06-08+19,900→ 19,900 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08+7,950→ 32,250 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-07$62.00/sh−2,433→ 24,400 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-06$61.37/sh−2,817→ 26,833 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-04-21−12,500→ 100,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-21$73.25/sh−9,824→ 29,650 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-21$42.54/sh+12,500→ 39,474 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-20$73.99/sh−9,764→ 26,974 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-04-20−12,500→ 112,500 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-20$42.54/sh+12,500→ 36,738 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-04-19−12,500→ 125,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-19$42.54/sh+12,500→ 33,559 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-19$72.25/sh−9,321→ 24,238 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-18$73.55/sh−8,941→ 21,059 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-04-18−12,500→ 137,500 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-18$42.54/sh+12,500→ 30,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-07-02$59.76/sh−421→ 17,500 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-09+7,000→ 17,500 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-06-09+17,500→ 17,500 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-07$60.50/sh−2,278→ 10,500 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-04$61.04/sh−1,222→ 12,778 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-01-06$60.81/sh−110→ 14,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-11-13$42.54/sh+25,000→ 39,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-11-13$63.51/sh−21,000→ 14,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2020-11-13−25,000→ 150,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-11-13$62.67/sh−4,000→ 35,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-09-17$42.54/sh+25,000→ 39,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-09-17$60.26/sh−2,888→ 14,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-09-17$59.75/sh−22,532→ 16,888 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2020-09-17−25,000→ 175,000 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2020-06-09+35,000→ 35,000 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-06-09+14,000→ 14,000 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2019-07-02+200,000→ 200,000 total

Companies

Recent Filings

Address

3451 PLANO PARKWAY

LEWISVILLE, TX, 75056

View on SEC.gov